Hot Features
プレミアム
Seres Therapeutics Inc (MCRB)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-15 | Mr. Eric D. ShaffDirector | -259.00 | 1.95k | Derivative Exercise and Sale | 7.53 | 12.04k | - |
| 2026-05-15 | Mr. Eric D. ShaffDirector | 463.00 | 0.00 | Derivative Exercise and Retained Stock | - | 12.04k | 4.00% |
| 2026-05-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -77.00 | 579.81 | Derivative Exercise and Sale | 7.53 | 7.84k | - |
| 2026-05-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 161.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.84k | 2.10% |
| 2026-05-15 | Ms. Kelly BradyExec. VP & COO | -59.00 | 444.27 | Derivative Exercise and Sale | 7.53 | 8.56k | - |
| 2026-05-15 | Ms. Kelly BradyExec. VP & COO | 121.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.56k | 1.43% |
| 2026-05-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -79.00 | 594.87 | Derivative Exercise and Sale | 7.53 | 7.95k | - |
| 2026-05-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 165.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.95k | 2.12% |
| 2026-02-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 166.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.79k | 2.18% |
| 2026-02-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -78.00 | 660.66 | Derivative Exercise and Sale | 8.47 | 7.79k | - |
| 2026-02-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 150.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.68k | 1.99% |
| 2026-02-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -89.00 | 753.83 | Derivative Exercise and Sale | 8.47 | 7.68k | - |
| 2026-02-15 | Dr. Teresa L. Youngインサイダー | 156.00 | 0.00 | Derivative Exercise and Retained Stock | - | 8.56k | 1.86% |
| 2026-02-15 | Dr. Teresa L. Youngインサイダー | -75.00 | 635.25 | Derivative Exercise and Sale | 8.47 | 8.56k | - |
| 2026-02-15 | Mr. Eric D. ShaffDirector | 464.00 | 0.00 | Derivative Exercise and Retained Stock | - | 11.58k | 4.18% |
| 2026-02-15 | Mr. Eric D. ShaffDirector | -259.00 | 2.19k | Derivative Exercise and Sale | 8.47 | 11.58k | - |
| 2025-11-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -1.26k | 21.75k | Derivative Exercise and Sale | 17.30 | 7.53k | - |
| 2025-11-15 | Mr. Eric D. ShaffDirector | 504.00 | 0.00 | Derivative Exercise and Retained Stock | - | 11.11k | 4.75% |
| 2025-11-15 | Mr. Eric D. ShaffDirector | -217.00 | 3.75k | Derivative Exercise and Sale | 17.30 | 11.11k | - |
| 2025-11-15 | Dr. Teresa L. Youngインサイダー | 3.19k | 0.00 | Derivative Exercise and Retained Stock | - | 8.40k | 61.09% |
| 2025-11-15 | Dr. Teresa L. Youngインサイダー | -1.04k | 18.03k | Derivative Exercise and Sale | 17.30 | 8.40k | - |
| 2025-11-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 168.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.62k | 2.25% |
| 2025-11-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -76.00 | 1.31k | Derivative Exercise and Sale | 17.30 | 7.62k | - |
| 2025-11-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 2.98k | 0.00 | Derivative Exercise and Retained Stock | - | 7.53k | 65.50% |
| 2025-08-15 | Mr. Eric D. ShaffDirector | 507.00 | 0.00 | Derivative Exercise and Retained Stock | - | 10.61k | 5.02% |
| 2025-08-15 | Mr. Eric D. ShaffDirector | -217.00 | 3.61k | Derivative Exercise and Sale | 16.65 | 10.61k | - |
| 2025-08-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | 168.00 | 0.00 | Derivative Exercise and Retained Stock | - | 7.46k | 2.31% |
| 2025-08-15 | Mr. Thomas J. DesRosierExec. VP, Chief Legal Officer & Secretary | -76.00 | 1.27k | Derivative Exercise and Sale | 16.65 | 7.46k | - |
| 2025-08-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | 165.00 | 0.00 | Derivative Exercise and Retained Stock | - | 4.55k | 3.76% |
| 2025-08-15 | Dr. Matthew R. HennPresident & Chief Scientific Officer | -73.00 | 1.22k | Derivative Exercise and Sale | 16.65 | 4.55k | - |
| 2025-08-15 | Dr. Teresa L. Youngインサイダー | 171.00 | 0.00 | Derivative Exercise and Retained Stock | - | 5.22k | 3.39% |
| 2025-08-15 | Dr. Teresa L. Youngインサイダー | -59.00 | 982.35 | Derivative Exercise and Sale | 16.65 | 5.22k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
